Abstract: Compositions and methods for treatment of autoimmune and inflammatory conditions which include Orthopox Major Histocompatibility complex (MHC) class I-like protein (OMCP) or a variant thereof.
Type:
Application
Filed:
August 13, 2020
Publication date:
October 13, 2022
Applicant:
COURIER THERAPEUTICS, INC.
Inventors:
Alexander Sasha KRUPNICK, Eric Reed LAZEAR, Sarah HEIN, Daniel Marvin WATKINS